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Publication bias
SIR—Chalmers and Moher's (Oct 30, p 1116) reaction to our
modest report about publication bias (Sept 4, p 621), seems to
stem from a simple view of the nature of medical progress.
They seem to believe that we can catch truth by amassing äs
much so-called objective data äs possible, thereby disregarding
the subjective nature of decisions about which data are
worthwhile. Even in the most formal type of clinical research,
the randomised controlled trial, subjective judgment plays a
large part. Subjectivity Starts with decisions about drug
dosage, timing, and inclusion and exclusion criteria, and
continues with all types of practical daily decisions—eg,
whether to stop a trial prematurely. It is most strongly present
in data analysis:1 should we adjust for imbalances after
randomisation in order to believe the results? The mere asking
of this question shows that decisions about the acceptance of a
particular randomisation are inherently subjective.2
Subjectivity, not surprisingly, is equally present in the decision
whether, when, and where to publish.
Subjective judgment is neither good nor bad, it is merely
inescapable and part of our human condition: facts do not exist
by themselves, but they become accepted because they fit a
certain theory.3·4 The results of a randomised controlled trial
will only be accepted if they fit the pre-existing convictions of at
least part of the medical Community—which is how progress is
made—and this is already apparent in the decision to adjust for
post-randomisation imbalances. It becomes even more clear
when we look at the Interpretation of a trial. For example, a
large and perfectly executed randomised 'trial showing a
pharmacological benefit of homoeopathy will be rejected out of
band, because dilutions beyond Avogadro's number forbid
biochemical activity. The trial will be seen äs a mere game of
chance between a placebo and an infinite dilution, which
accidentally came out positive. Likewise, physicians will throw
away glossy advertisements with impressive p-values showing
niemory improvements in dementing elderly persons who use
some new vasodilator: it simply cannot be. In its lesser
extremes, this mechanism accounts for citation bias.
Publication bias, like citation bias, is only part of subjective
judgment that we should gladly enjoy to make meaningful
contributions to medicine.
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Influenza and meningococcal disease
SlR—Since 1984 the annual incidence of meningococcal
disease in England and Wales has increased, but between 1988
and 1992, with one exception, it has remained at a steady high
level and may now have begun to decline. The winter of
1989/90 showed a peak incidence of meningococcal disease and
this was associated with the widespread outbreak of influenza
in November/December, 1989.1 Lately the reports of
influenza-like illness from the Royal College of General
Practitioners have risen sharply although not synchronously in
all regions. At the Public Health Laboratory Service
Meningococcal Reference Unit, strains of meningococci are
received from laboratories in England and Wales from most
laboratory-proven cases.
In November, 1993,162 such isolateswere received, whereas
in November, 1992, 107 strains were submitted. This
represents a striking difference at a time when the perception of
the level of meningococcal disease in England and Wales is that
it is at least steady and may be declining. This temporal
increase in infections probably represents the effect of
influenza and perhaps other respiratory viruses on the
occurrence of meningococcal disease. Precisely how this
interaction is mediated remains obscure, the meningococcal
infections arise in the wake of the virus infections so it is at least
a possibility that some modulation of the immune response
occurs, rendering some individuals more susceptible to
meningococcal infection. How long such an influence might
last in an individual is conjectural. The early Symptoms of both
the viral and bacterial infections may be very similar and not
very specific, so it is most important for practitioners to be
aware that although meningococcal infection is fairly
uncommon, there is an increased likelihood of meningococcal
disease in winters when there are many influenza infections in
the Community.
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Commercialisation and medical education in
India
SlR—It is a pity that the authorities in India seem to be
preoccupied with the commercial interests associated with
medical education, however undesirable they may be (see
Kumar, Nov 13, p 1227). The policy of capitation fees can never
be condoned, but the disadvantage of examining this policy in
Isolation may mean undervaluation of the contribution the
private medical Colleges make to health care of the communities
in India: the fact that most of these Colleges make health care
accessible to communities, especially in rural areas, should not
be overlooked.
As Kumar's report suggests many of these institutions have
their own hospitals for teaching purposes, and these hospitals
do provide health care to the populations surrounding them.
Without these hospitals much of the essen tial health care would
not be available to the local people. Accessibility is a major
difficulty for much of the rural population and I believe that the
private medical Colleges have attempted to meet this need.
Instead of attempts to curb commercialisation of the
Colleges, which may result in their extinction, what is needed is
a comprehensive examination of the contribution private
medical Colleges make to wider health care, with a view to
reaching a consensus on how this effort can be encouraged
without compromising Standards of medical education or
profitable Operation of the Colleges. The Indian cabinet sub-
commitee perhaps should enlarge its remit to include this issue.
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Does cyclosporin affect lipoprotein(a)
concentrations?
SlR—Lipoprotein(a) concentrations have been found to be
higher in renal transplant recipients treated with cyclosporin
than in those maintained on azathioprine and prednisolone.1
Moreover, we have shown that lipoprotein(a) is an important,
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